Logo image of MTD

METTLER-TOLEDO INTERNATIONAL (MTD) Stock Fundamental Analysis

NYSE:MTD - New York Stock Exchange, Inc. - US5926881054 - Common Stock - Currency: USD

1286.54  -16.59 (-1.27%)

After market: 1286.54 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MTD. MTD was compared to 57 industry peers in the Life Sciences Tools & Services industry. While MTD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. MTD has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

9

1. Profitability

1.1 Basic Checks

In the past year MTD was profitable.
MTD had a positive operating cash flow in the past year.
Each year in the past 5 years MTD has been profitable.
MTD had a positive operating cash flow in each of the past 5 years.
MTD Yearly Net Income VS EBIT VS OCF VS FCFMTD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

With an excellent Return On Assets value of 26.64%, MTD belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 44.86%, MTD belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for MTD is significantly above the industry average of 9.60%.
The 3 year average ROIC (41.86%) for MTD is below the current ROIC(44.86%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 26.64%
ROE N/A
ROIC 44.86%
ROA(3y)25.04%
ROA(5y)23.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)41.86%
ROIC(5y)39.3%
MTD Yearly ROA, ROE, ROICMTD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

The Profit Margin of MTD (22.29%) is better than 100.00% of its industry peers.
MTD's Profit Margin has improved in the last couple of years.
MTD's Operating Margin of 29.23% is amongst the best of the industry. MTD outperforms 100.00% of its industry peers.
MTD's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 60.06%, MTD belongs to the top of the industry, outperforming 85.96% of the companies in the same industry.
MTD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 29.23%
PM (TTM) 22.29%
GM 60.06%
OM growth 3Y2.77%
OM growth 5Y3.56%
PM growth 3Y2.52%
PM growth 5Y3.63%
GM growth 3Y0.93%
GM growth 5Y0.74%
MTD Yearly Profit, Operating, Gross MarginsMTD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

MTD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, MTD has less shares outstanding
The number of shares outstanding for MTD has been reduced compared to 5 years ago.
Compared to 1 year ago, MTD has a worse debt to assets ratio.
MTD Yearly Shares OutstandingMTD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
MTD Yearly Total Debt VS Total AssetsMTD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 10.83 indicates that MTD is not in any danger for bankruptcy at the moment.
MTD has a Altman-Z score of 10.83. This is amongst the best in the industry. MTD outperforms 94.74% of its industry peers.
MTD has a debt to FCF ratio of 2.33. This is a good value and a sign of high solvency as MTD would need 2.33 years to pay back of all of its debts.
MTD has a Debt to FCF ratio of 2.33. This is amongst the best in the industry. MTD outperforms 89.47% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.33
Altman-Z 10.83
ROIC/WACC4
WACC11.21%
MTD Yearly LT Debt VS Equity VS FCFMTD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

MTD has a Current Ratio of 1.02. This is a normal value and indicates that MTD is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.02, MTD is not doing good in the industry: 84.21% of the companies in the same industry are doing better.
A Quick Ratio of 0.73 indicates that MTD may have some problems paying its short term obligations.
The Quick ratio of MTD (0.73) is worse than 91.23% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.73
MTD Yearly Current Assets VS Current LiabilitesMTD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.09% over the past year.
Measured over the past years, MTD shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.53% on average per year.
MTD shows a small growth in Revenue. In the last year, the Revenue has grown by 2.22%.
MTD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.18% yearly.
EPS 1Y (TTM)8.09%
EPS 3Y6.67%
EPS 5Y12.53%
EPS Q2Q%32.02%
Revenue 1Y (TTM)2.22%
Revenue growth 3Y1.37%
Revenue growth 5Y5.18%
Sales Q2Q%11.78%

3.2 Future

Based on estimates for the next years, MTD will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.45% on average per year.
The Revenue is expected to grow by 4.78% on average over the next years.
EPS Next Y4.79%
EPS Next 2Y7.62%
EPS Next 3Y9%
EPS Next 5Y9.45%
Revenue Next Year2.55%
Revenue Next 2Y3.98%
Revenue Next 3Y4.33%
Revenue Next 5Y4.78%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
MTD Yearly Revenue VS EstimatesMTD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B 5B
MTD Yearly EPS VS EstimatesMTD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20 40 60

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 31.26 indicates a quite expensive valuation of MTD.
Compared to the rest of the industry, the Price/Earnings ratio of MTD indicates a somewhat cheap valuation: MTD is cheaper than 70.18% of the companies listed in the same industry.
MTD is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 29.83 indicates a quite expensive valuation of MTD.
Based on the Price/Forward Earnings ratio, MTD is valued a bit cheaper than 66.67% of the companies in the same industry.
MTD is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 31.26
Fwd PE 29.83
MTD Price Earnings VS Forward Price EarningsMTD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MTD is valued a bit cheaper than the industry average as 71.93% of the companies are valued more expensively.
MTD's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MTD is cheaper than 75.44% of the companies in the same industry.
Industry RankSector Rank
P/FCF 31.13
EV/EBITDA 23.28
MTD Per share dataMTD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100 150

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MTD does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of MTD may justify a higher PE ratio.
PEG (NY)6.53
PEG (5Y)2.49
EPS Next 2Y7.62%
EPS Next 3Y9%

More info and screens

0

5. Dividend

5.1 Amount

MTD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

METTLER-TOLEDO INTERNATIONAL

NYSE:MTD (2/21/2025, 8:35:18 PM)

After market: 1286.54 0 (0%)

1286.54

-16.59 (-1.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-06 2025-02-06/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners98.96%
Inst Owner Change1.36%
Ins Owners0.4%
Ins Owner Change-0.4%
Market Cap26.91B
Analysts65.26
Price Target1391.63 (8.17%)
Short Float %1.98%
Short Ratio3.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.98%
Min EPS beat(2)1.02%
Max EPS beat(2)4.94%
EPS beat(4)4
Avg EPS beat(4)6.72%
Min EPS beat(4)1.02%
Max EPS beat(4)15.16%
EPS beat(8)6
Avg EPS beat(8)2.47%
EPS beat(12)10
Avg EPS beat(12)3.23%
EPS beat(16)14
Avg EPS beat(16)4.26%
Revenue beat(2)2
Avg Revenue beat(2)1.3%
Min Revenue beat(2)0.04%
Max Revenue beat(2)2.56%
Revenue beat(4)4
Avg Revenue beat(4)1.93%
Min Revenue beat(4)0.04%
Max Revenue beat(4)4.21%
Revenue beat(8)5
Avg Revenue beat(8)-0.03%
Revenue beat(12)9
Avg Revenue beat(12)0.48%
Revenue beat(16)13
Avg Revenue beat(16)1.11%
PT rev (1m)0.69%
PT rev (3m)-2.8%
EPS NQ rev (1m)-5.86%
EPS NQ rev (3m)-17.45%
EPS NY rev (1m)0.88%
EPS NY rev (3m)-2.97%
Revenue NQ rev (1m)-3.47%
Revenue NQ rev (3m)-7.9%
Revenue NY rev (1m)-0.33%
Revenue NY rev (3m)-1.05%
Valuation
Industry RankSector Rank
PE 31.26
Fwd PE 29.83
P/S 6.95
P/FCF 31.13
P/OCF 27.79
P/B N/A
P/tB N/A
EV/EBITDA 23.28
EPS(TTM)41.16
EY3.2%
EPS(NY)43.13
Fwd EY3.35%
FCF(TTM)41.32
FCFY3.21%
OCF(TTM)46.29
OCFY3.6%
SpS185.1
BVpS-6.07
TBVpS-50.33
PEG (NY)6.53
PEG (5Y)2.49
Profitability
Industry RankSector Rank
ROA 26.64%
ROE N/A
ROCE 54.63%
ROIC 44.86%
ROICexc 46.18%
ROICexgc 85.55%
OM 29.23%
PM (TTM) 22.29%
GM 60.06%
FCFM 22.32%
ROA(3y)25.04%
ROA(5y)23.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)41.86%
ROIC(5y)39.3%
ROICexc(3y)43.32%
ROICexc(5y)40.86%
ROICexgc(3y)78.59%
ROICexgc(5y)73.33%
ROCE(3y)50.98%
ROCE(5y)47.86%
ROICexcg growth 3Y5.41%
ROICexcg growth 5Y8.89%
ROICexc growth 3Y5.36%
ROICexc growth 5Y6.84%
OM growth 3Y2.77%
OM growth 5Y3.56%
PM growth 3Y2.52%
PM growth 5Y3.63%
GM growth 3Y0.93%
GM growth 5Y0.74%
F-Score7
Asset Turnover1.2
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.33
Debt/EBITDA 1.46
Cap/Depr 84.32%
Cap/Sales 2.68%
Interest Coverage 14.91
Cash Conversion 77.15%
Profit Quality 100.15%
Current Ratio 1.02
Quick Ratio 0.73
Altman-Z 10.83
F-Score7
WACC11.21%
ROIC/WACC4
Cap/Depr(3y)92.83%
Cap/Depr(5y)94.35%
Cap/Sales(3y)2.85%
Cap/Sales(5y)2.89%
Profit Quality(3y)97.94%
Profit Quality(5y)100.58%
High Growth Momentum
Growth
EPS 1Y (TTM)8.09%
EPS 3Y6.67%
EPS 5Y12.53%
EPS Q2Q%32.02%
EPS Next Y4.79%
EPS Next 2Y7.62%
EPS Next 3Y9%
EPS Next 5Y9.45%
Revenue 1Y (TTM)2.22%
Revenue growth 3Y1.37%
Revenue growth 5Y5.18%
Sales Q2Q%11.78%
Revenue Next Year2.55%
Revenue Next 2Y3.98%
Revenue Next 3Y4.33%
Revenue Next 5Y4.78%
EBIT growth 1Y4.43%
EBIT growth 3Y4.18%
EBIT growth 5Y8.92%
EBIT Next Year9.58%
EBIT Next 3Y8.74%
EBIT Next 5Y7.97%
FCF growth 1Y0.45%
FCF growth 3Y2.57%
FCF growth 5Y11.3%
OCF growth 1Y0.26%
OCF growth 3Y2.14%
OCF growth 5Y9.92%